ArticleInsights into imaging2026
ESUR female pelvis group approach to cystic female pelvic lesions.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cystic female pelvic lesions, whether of ovarian or non-ovarian origin, are prevalent in routine clinical practice, with the majority originating from gynaecological (ovarian) structures, ranging from functional cysts to malignant ovarian tumours. Despite the fact that we encounter these lesions in the course of our routine clinical work, arriving at an accurate diagnosis can often prove challenging due to the overlap of imaging appearances. Ultrasound is the primary imaging modality for the evaluation of most cystic female pelvic lesions, while MRI serves as a problem-solving tool. In cases that are more complex or equivocal, pelvic MRI proved to be particularly useful due to its superior soft tissue resolution, multiplanar imaging capability and non-invasive nature. In order to make an accurate diagnosis, it is crucial to have a comprehensive understanding of pelvic topographic anatomy, be familiar with possible differential diagnoses and include all relevant clinical data. The classification of ovarian cystic lesions was undertaken using the O-RADS MRI risk stratification system, which provides standardised language for communication between radiologists and clinicians. The objective of this review is to illustrate the spectrum of typical MRI characteristics of different cystic female lesions of both ovarian and non-ovarian origin, with the emphasis on differential diagnoses. The review includes tables with MRI appearances on T2, T1, DWI sequences and postcontrast tomograms. To facilitate the learning process, schematic representations of MRI appearances of ovarian lesions have been incorporated. CRITICAL RELEVANCE STATEMENT: MRI diagnosis of various ovarian and non-ovarian cystic female pelvic lesions and their differential diagnosis. KEY POINTS: The diagnosis of cystic female pelvic lesions can be challenging due to the overlapping imaging characteristics exhibited by these lesions. Discrimination between ovarian and non-ovarian lesions is of paramount importance, given the existence of marked discrepancies in both prognosis and management. If the lesion is of ovarian origin, the O-RADS MRI risk stratification system should be implemented in order to ascertain the risk of malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.